Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2007 / Cilt: 41 - Sayı: 4

The quality of life in patients with psoriasis

Psoriasisli hastalarda yaşam kalitesi

Pages
117–120
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients especially young, with a long duration and a severe disease should be evaluated for the neseccity of psychiatric support in addition to the classical therapy. (Turkderm 2007; 41: 117-20)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Psoriasis is a chronic skin disease requiring recurrent treatment and causing cosmetical problems.
📊
Key Findings & Data:Material and Method: “Psoriasis Quality of Life Questionnaire” was completed by 124 patients.
💡
Conclusion & Impact:Patients especially young, with a long duration and a severe disease should be evaluated for the neseccity of psychiatric support in addition to the classical therapy. (Turkderm 2007; 41: 117-20)
🔬Design:Survey & Empirical Study
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Psoriasis is a chronic skin disease requiring recurrent treatment and causing cosmetical problems. Therefore it affects patients’ lives negatively. Opinions upon apperance, social relationships and daily activities alter due to cultural and religious factors in distinct populations. In this study we aimed to investigate the quality of life of patients in our population. Material and Method: “Psoriasis Quality of Life Questionnaire” was completed by 124 patients. Disease severity was scored with Psoriasis Area Severity Index (PASI). Patients’ ages, sexes and illness duration were recorded. Joint involvement was also searched. The relationship between total quality of life score and each item was investigated. Results: Quality of life was worse in young patients (r = -0.19, P = 0.037) and in patients with a longer duration (r = 0.20, P = 0.026) or severe disease (r = 0.29, P = 0.002). No effect of age and arthritis on life quality was established (P>0.05). Men described more that people moved away by thinking of the contaquisity of the disease, hesitation of going to public places and negative influence on sex life when compared to women (p=0.009, p=0.003, p=0.001). Psychosocial problems (98.4%) were accepted more important than problems in daily activities (95.2%) and concerns about therapy (76.6%). Conclusion: Psoriasis constitutes a great concern in patients’ lives. Patients especially young, with a long duration and a severe disease should be evaluated for the neseccity of psychiatric support in addition to the classical therapy. (Turkderm 2007; 41: 117-20)

Özet

Psoriasis kozmetik problemlere yol açan ve aral›kl› tedavi gerektiren kronik bir deri hastal›¤›d›r. Bu nedenle, hastalar› n yaflamlar›n› olumsuz yönde etkiler. D›fl görünümle ilgili yarg›lar, sosyal iliflkiler ve günlük aktiviteler farkl› toplumlarda kültürel ve dinsel faktörler do¤rultusunda de¤ifliklik gösterir. Bu çal›flmada, toplumumuzda psoriasisli hastalar›n yaflam kalitelerini araflt›rmay› amaçlad›k. Gereç ve Yöntem: “Psoriasis Yaflam Kalite Ölçe¤i (PYKÖ)” 124 hasta taraf›ndan yan›tland›. Hastal›k fliddeti “Psoriasis Area Severity Index (PASI)” ile hesapland›. Hastalar›n yafllar›, cinsiyetleri ve hastal›k süreleri kaydedildi. Eklem tutulumu araflt›r›ld›. Her bir parametrenin PYKÖ skoru ile iliflkisi araflt›r›ld›. Bulgular: Yaflam kalitesi gençlerde (r = -0.19, P = 0.037), hastal›¤› uzun süredir (r = 0.20, P = 0.026) ve daha fliddetli olan (r = 0.29, P = 0.002) hastalarda daha kötüydü. Yaflam kalitesi ile cinsiyet ve psoriatik artrit varl›¤› aras›nda iliflki saptanmad› (p>0.05). Hastal›¤›n bulafl›c› oldu¤unu düflünerek insanlar›n kendinden uzak durdu¤unu, insanlar›n toplu halde bulundu¤u yerlere gitmeye çekindi¤ini ve cinsel yaflam›n›n etkilendi¤ini tan›mlayan erkek hastalar kad›nlara oranla daha fazlayd› (p=0.009, p=0.003, p=0.001). Psikososyal sorunlar (%98.4) günlük aktivitelerdeki problemlerden (%95.2) ve tedavi ile ilgili kayg›lardan daha önemli kabul edilmekteydi. Sonuç: Psoriasis hastalar›n yaflamlar›nda önemli bir sorun teflkil etmektedir. Özellikle genç, hastal›¤› fliddetli seyreden ve uzun süredir mevcut olan hastalar klasik tedaviye ek olarak psikiyatrik destek gereklili¤i aç›s›ndan da de¤erlendirilmelidir. (Turkderm 2007; 41: 117-20)

🔖

Cite This Article

ERDOĞAN, Ş. B., KAÇAR, N., ERGİN, Ş. (2022). The quality of life in patients with psoriasis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 41 - Sayı: 4, 117–120. https://ajindex.com/articles/622139

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, Sigurgeirsson B: Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-16
  2. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ: Determinants of quality of life in patients with psoriasis: A study from the US population. J Am Acad Dermatol 2004; 51: 704-8
  3. Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D: The Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group: Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006; 154: 325-31
  4. Mease PJ, Menter MA: Quality-of-life in psoriasis and psoriatic arthritis: Outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol 2006; 54: 685-704
  5. AJ Russo P, Ilchef R, Cooper AJ: Psychiatric morbidity in psoriasis: A review. Australas J Dermatol 2004; 45: 155-61
  6. Psoriasis statistics. National Psoriasis Foundation, at: http:/www.psoriasis.org/stat.html. (Accessed 31 July 2000.
  7. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI)- a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6
  8. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ: Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13
  9. Morgan M, McCreedy R, Simpson J, Hay RJ: Dermatology quality of life scales- a measure of the impact of skin diseases. Br J Dermatol 1997; 136: 202-6
  10. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G: Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289-95. 11. ‹nan›r I, Aydemir Ö, Gündüz K, Danac› EA, Ermertcan TA: Psoriasisli hastalarda yaflam kalite ölçe¤i gelifltirilmesi. Türkderm 2003; 37: 189-95
  11. Gupta MA, Gupta AK: Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-50
  12. Akay A, Pekcanlar A, Bozda¤ KE, Alt›ntafl L, Karaman A: Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol; 16: 347-52
  13. Rapp SR, Cottrell CA, Leary MR: Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol 2001; 145: 610-6
  14. Gladmann DD: Psoriatic arthritis. D